1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Maryland >
  6. Vigene Biosciences Acquires Omnia Biologics

M&A Deal Summary

Vigene Biosciences Acquires Omnia Biologics

On November 29, 2016, Vigene Biosciences acquired life science company Omnia Biologics

Acquisition Highlights
  • This is Vigene Biosciences’ 1st transaction in the Life Science sector.
  • This is Vigene Biosciences’ 1st transaction in the United States.
  • This is Vigene Biosciences’ 1st transaction in Maryland.

M&A Deal Summary
Date 2016-11-29
Target Omnia Biologics
Sector Life Science
Buyer(s) Vigene Biosciences
Deal Type Add-on Acquisition

Target

Omnia Biologics

Rockville, Maryland, United States
Omnia Biologics, Inc. is a provider of cGMP production and process development services for gene therapeutics through commercial recombinant proteins.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Vigene Biosciences

Rockville, Maryland, United States
Category Company
Founded 2012
Sector Life Science
DESCRIPTION

Vigene Biosciences is a viral vector based gene delivery for both life science research, gene therapy and cell therapy purposes. Vigene offers AAV, lentivirus, and adenovirus based products and custom services. Vigene Biosciences was founded in 2012 and is based in Rockville, Maryland.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Maryland M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal